{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:47:50Z","timestamp":1792064870528,"version":"4.4.0"},"reference-count":22,"publisher":"Baskent University","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.6002\/ect.2026.0025","type":"journal-issue","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:24:44Z","timestamp":1791977084000},"source":"Crossref","is-referenced-by-count":0,"title":[],"prefix":"10.6002","volume":"24","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Feng G, Yilmaz Y, Valenti L, et al. Global burden of major chronic liver diseases in 2021. Liver Int. 2025;45(4):e70058. doi:10.1111\/liv.70058","DOI":"10.1111\/liv.70058"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Im YR, Jagdish R, Leith D, et al. Prevalence of occult hepatitis B virus infection in adults: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(10):932-942. doi:10.1016\/S2468-1253(22)00201-1","DOI":"10.1016\/S2468-1253(22)00201-1"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Alaama AS, Khattabi H, Mugisa B, Atta H, Hermez J, Hutin YJ. Progress towards elimination of viral hepatitis by 2030 in the WHO Eastern Mediterranean Region, 2019. Lancet Gastroenterol Hepatol. 2022;7(9):862-870. doi:10.1016\/S2468-1253(22)00082-6","DOI":"10.1016\/S2468-1253(22)00082-6"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Abakay S, D\u00f6ngelli H, Dan\u0131\u015f N, et al. Prevalence and screening rates of hepatitis B and hepatitis C infections in adult patients with solitary organ tumors. Trop Med Infect Dis. 2025;10(9):258. doi:10.3390\/tropicalmed10090258","DOI":"10.3390\/tropicalmed10090258"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Akarsu M, Dolu S, Harputluoglu M, et al. Changing trends in the etiology of liver transplantation in T\u00fcrkiye: a multicenter study. Hepatol Forum. 2024;5(1):3-6. doi:10.14744\/hf.2023.2023.0010","DOI":"10.14744\/hf.2023.2023.0010"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Howell J, Seaman C, Wallace J, et al. Pathway to global elimination of hepatitis B: HBV cure is just the first step. Hepatology. 2023;78(3):976-990. doi:10.1097\/HEP.0000000000000430","DOI":"10.1097\/HEP.0000000000000430"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. D\u00f6ngelli H, Dan\u0131\u015f N, \u00dcnek T, et al. Comparative analysis of tenofovir alafenamide and entecavir on renal function and serum lipids in liver transplant recipients: a controlled retrospective cohort study. BMC Gastroenterol. 2025;25(1):645. doi:10.1186\/s12876-025-04262-7","DOI":"10.1186\/s12876-025-04262-7"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Burra P, Battistella S, Turco L, et al. Liver transplantation for HBV-related liver disease: impact of prophylaxis for HBV on HCC recurrence. JHEP Rep. 2024;7(3):101278. doi:10.1016\/j.jhepr.2024.101278","DOI":"10.1016\/j.jhepr.2024.101278"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Duvoux C, Belli LS, Fung J, et al. 2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation. Aliment Pharmacol Ther. 2021;54(5):583-605. doi:10.1111\/apt.16374","DOI":"10.1111\/apt.16374"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Akarsu M, Onem S, Turan I, et al. Recommendations for hepatitis B immunoglobulin and antiviral prophylaxis against hepatitis B recurrence after liver transplantation. Turk J Gastroenterol. 2021;32(9):712-719. doi:10.5152\/tjg.2021.21608","DOI":"10.5152\/tjg.2021.21608"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Lai Q, Mennini G, Giovanardi F, Rossi M, Giannini EG. Immunoglobulin, nucleos(t)ide analogues and hepatitis B virus recurrence after liver transplant: a meta-analysis. Eur J Clin Invest. 2021;51(8):e13575. doi:10.1111\/eci.13575","DOI":"10.1111\/eci.13575"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Lucey MR, Terrault N, Ojo L, et al. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl. 2013;19(1):3-26. doi:10.1002\/lt.23566","DOI":"10.1002\/lt.23566"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Liu M, Sun LY, Zhu ZJ, Wu SS. Risk factors for recurrent hepatitis B after liver transplantation: a systematic review and meta-analysis. Chin Med J (Engl). 2021;134(19):2388-2390. doi:10.1097\/CM9.0000000000001580","DOI":"10.1097\/CM9.0000000000001580"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Baskiran A, Akbulut S, Sahin TT, et al. Effect of HBV-HDV co-infection on HBV-HCC co-recurrence in patients undergoing living donor liver transplantation. Hepatol Int. 2020;14(5):869-880. doi:10.1007\/s12072-020-10085-3","DOI":"10.1007\/s12072-020-10085-3"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kim KD, Lee JE, Kim JM, et al. Cost-effectiveness and long-term outcomes of liver transplantation using hepatitis B core antibody-positive grafts with hepatitis B immunoglobulin prophylaxis in Korea. Clin Mol Hepatol. 2021;27(4):603-615. doi:10.3350\/cmh.2021.0137","DOI":"10.3350\/cmh.2021.0137"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Burra P, Germani G, Adam R, et al. Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. J Hepatol. 2013;58(2):287-296. doi:10.1016\/j.jhep.2012.10.016","DOI":"10.1016\/j.jhep.2012.10.016"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Kushner T, Da BL, Chan A, Dieterich D, Sigel K, Saberi B. Liver transplantation for hepatitis D virus in the United States: a UNOS study on outcomes in the MELD era. Transplant Direct. 2021;8(1):e1253. doi:10.1097\/TXD.0000000000001253","DOI":"10.1097\/TXD.0000000000001253"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Serin A, Sahin T, Arikan BT, Emek E, Bozkurt B, Tokat Y. A changing etiologic scenario in liver transplantation: a single-center cohort study from Turkey. Transplant Proc. 2019;51(7):2416-2419. doi:10.1016\/j.transproceed.2019.01.190","DOI":"10.1016\/j.transproceed.2019.01.190"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Li MS, Hou ZH, Yao GZ, Tan M. The strategy and efficacy of prophylaxis against hepatitis B virus recurrence after liver transplantation for HBV-related diseases in the era of potent nucleos(t)ide analogues: a meta-analysis. J Dig Dis. 2021;22(2):91-101. doi:10.1111\/1751-2980.12959","DOI":"10.1111\/1751-2980.12959"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Na GH, Kim DG, Han JH, et al. Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation. J Gastroenterol Hepatol. 2014;29(1):151-156. doi:10.1111\/jgh.12403","DOI":"10.1111\/jgh.12403"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Yu J, Ye Y, Liu J, et al. The role of hepatitis B core-related antigen in predicting hepatitis B virus recurrence after liver transplantation. Aliment Pharmacol Ther. 2019;50(9):1025-1036. doi:10.1111\/apt.15429","DOI":"10.1111\/apt.15429"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Teegen EM, Maurer MM, Globke B, Pratschke J, Eurich D. Liver transplantation for Hepatitis-B-associated liver disease - three decades of experience. Transpl Infect Dis. 2019;21(1):e12997. doi:10.1111\/tid.12997","DOI":"10.1111\/tid.12997"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:55:18Z","timestamp":1792061718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/current\/2026\/24\/9\/0\/728\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2026.0025","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}